Enterococci with special Resistance - Epidemiology, Hygiene and Therapy

被引:4
|
作者
Mischnik, Alexander [1 ,2 ]
Werner, Guido [3 ,4 ]
Bender, Jennifer [3 ,4 ]
Mutters, Nico Tom [5 ,6 ,7 ]
机构
[1] Univ Klinikum Schleswig Holstein, Klin Infektiol & Mikrobiol, Campus Lubeck,Ratzeburger Allee 160, D-23562 Lubeck, Germany
[2] Univ Klinikum Schleswig Holstein, Deutsch Zentrum Infekt Forsch, Campus Lubeck, Lubeck, Germany
[3] Robert Koch Inst, Fachgebiets Nosokomiale Infekt Erreger & Antibiot, Berlin, Germany
[4] Robert Koch Inst, Natl Referenzzentrums Staphylokokken & Enterokokk, Bereich Wernigerode, Berlin, Germany
[5] Univ Klinikum Freiburg, Facharzt Mikrobiol, Freiburg, Germany
[6] Univ Klinikum Freiburg, Facharzt Hyg & Umweltmed, Freiburg, Germany
[7] Univ Klinikum Freiburg, Inst Infekt Pravent & Krankenhaushyg, Freiburg, Germany
关键词
DAPTOMYCIN; TIGECYCLINE; FAECIUM; METAANALYSIS; COMBINATION; SAFETY; VRE;
D O I
10.1055/a-0655-6454
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Enterococci with special resistance patterns (mainly vancomycin-resistant enterococci) play an important role in everyday clinical practice. Rising resistance rates to linezolid, daptomycin or tigecycline are also increasingly reported. Therapeutically, linezolid and daptomycin are the most important substances mainly in infections due to vancomycin-resistant enterococci. Several systematic meta-analyses of bloodstream infections showed discrepant results in the comparison of mortality of linezolid and daptomycin-treated bacteraemias. The containment of enterococci with special resistance patterns is currently receiving great attention. The key hygienic issue in all recommendations for dealing with multidrug-resistant enterococci can be summarized very simply: current scientific evidence is often inconsistent and studies that have clearly tested a single intervention for efficacy are lacking. The present work gives an insight into the current epidemiology and therapeutic strategies. Furthermore, the recently published German KRINKO recommendations are presented. © Georg Thieme Verlag KG, Stuttgart New York.
引用
收藏
页码:553 / 560
页数:8
相关论文
共 50 条
  • [1] Epidemiology and mechanisms of glycopeptide resistance in enterococci
    Zirakzadeh, A
    Patel, R
    CURRENT OPINION IN INFECTIOUS DISEASES, 2005, 18 (06) : 507 - 512
  • [2] Epidemiology of antimicrobial resistance in enterococci in France
    Bourdon, N.
    JOURNAL DES ANTI-INFECTIEUX, 2011, 13 (01) : 2 - 11
  • [3] Epidemiology of antimicrobial resistance in enterococci of animal origin
    Hershberger, E
    Oprea, SF
    Donabedian, SM
    Perri, M
    Bozigar, P
    Bartlett, P
    Zervos, MJ
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (01) : 127 - 130
  • [5] THE EPIDEMIOLOGY OF ENTEROCOCCI
    CHENOWETH, C
    SCHABERG, D
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1990, 9 (02) : 80 - 89
  • [6] Molecular epidemiology of enterococci with high-level resistance to aminoglycosides
    Privitera, O
    Agodi, A
    Puntorieri, M
    Primavera, A
    Santagati, M
    Privitera, A
    Mezzatesta, ML
    Giuffrida, E
    Stefani, S
    MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1995, 1 (04): : 293 - 297
  • [7] Epidemiology of the genetic elements responsible for acquired glycopeptide resistance in enterococci
    Woodford, N
    MICROBIAL DRUG RESISTANCE, 2001, 7 (03) : 229 - 236
  • [8] Genomic epidemiology reveals multiple mechanisms of linezolid resistance in clinical enterococci in China
    Wang, Ziran
    Liu, Danping
    Zhang, Jingjia
    Liu, Lingli
    Zhang, Zeming
    Liu, Chang
    Hu, Songnian
    Wu, Linhuan
    He, Zilong
    Sun, Hongli
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2024, 23 (01)
  • [9] Epidemiology and control of multiresistant enterococci
    Leclercq, R
    DRUGS, 1996, 52 : 47 - 49
  • [10] Enterococci and vancomycin resistance
    French, GL
    CLINICAL INFECTIOUS DISEASES, 1998, 27 : S75 - S83